As the cell and gene therapy pipeline grows, sponsors face a critical challenge: limited site capacity. This webinar brings together experts from sponsors, CROs, clinical sites, and IBCs to share actionable strategies for expanding your site network, accelerating study start-up, and ensuring regulatory readiness.

Key Takeaways

Identify and evaluate emerging sites, including underutilized or naïve centers.
De-risk site selection and accelerate start-up with CRO strategies and training.
Implement site-level best practices for CGT centers of excellence.
Ensure regulatory readiness with practical IBC guidance and centralized models.

The insights shared in this webinar will help you build more efficient, high-quality trials that advance your programs with confidence.

If you’d like to continue the conversation, we invite you to connect with our speakers to discuss your specific challenges or opportunities in cell and gene therapy studies.